Cambridge Consultants’ partner Saranas secures de novo classification from US FDA

Feb 17, 2020

Cambridge Consultants congratulates its client Saranas, Inc. on reaching a series of significant milestones. The Saranas Early Bird™ Bleed Monitoring System has been granted de novo classification by the United States Food and Drug Administration (FDA), becoming the first and only device on the market for early bleed detection during endovascular procedures. In addition, Saranas released a study of the first human results, which shows that the device is effective in the early detection of internal bleeding. Finally, the company has seen its first commercial use cases in the United States.

Cambridge Consultants has been a partner to Saranas since their startup origins. Beginning in 2015, the two companies embarked on a design journey with the goal of moving from a technology concept to a coherent system. Since then, Cambridge Consultants has been one of a small group of partners that supported Saranas through the many challenges of medical device development and regulatory approval.

Saranas chose to partner with Cambridge Consultants as it has all of the required capabilities and disciplines under one roof, from mechanical engineering to human factors and industrial design. Cambridge Consultants is a multi-disciplinary partner with decades of development experience in the medtech space, even providing a simulated operating room where technologies can be tested in a realistic environment.

We design disruptive technology to revolutionize diagnosis and treatment.

From the beginning, Cambridge Consultants’ approach was to frame the design challenge from a holistic point of view, focusing on feasibility, usability, desirability and viability. By designing the product to meet these competing needs it was possible to maintain the integrity of design when additional specialist partners were engaged to continue the development process.

The team used an integrated design approach to gather user needs and set requirements. This led to a design that could deliver the hardware and software functionality needed to perform bleed detection, while also being elegant and unobtrusive to clinicians. The technology, design language and Saranas brand were all considered simultaneously as the design evolved to its final form, allowing it to meet both technical and commercial goals.

Zaffer Syed, President and CEO of Saranas, Inc. commented: “Cambridge Consultants has been a vital partner as we moved from a technology capability to a commercial product. Their laser focus on user needs and systematic approach ensured that design integrity was retained throughout our journey to commercial launch.”

Serge Roux, Associate Director at Cambridge Consultants, commented: “We share the pride that Saranas, Inc. is feeling at securing de novo classification from the FDA, and congratulate the Saranas team, which has shown great determination and a singular focus on improving patient outcomes through the early detection of internal bleeds. Bringing a new, regulated medical device to market is amongst the most difficult challenges that a startup can take on. It requires vision, determination, investment and of course selection of the right development partners.”

Notes to editors

About Saranas

Saranas is a privately held Houston-based medical device company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications. The company’s patented Early Bird Bleed Monitoring System for vascular access procedures enables physicians to mitigate downstream consequences by addressing bleeding complications immediately, improving patient outcomes and lowering healthcare costs. For more information, please visit:

About Cambridge Consultants and Capgemini

About Cambridge Consultants
Cambridge Consultants develops breakthrough products, services and intellectual property, and provides business consultancy in technology-critical issues for clients worldwide. For more than 60 years, the company has been helping its clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies. With a team of more than 800 team members, including engineers, scientists, mathematicians and designers, in offices in Cambridge (UK), Boston (USA), Tokyo (Japan) and Singapore, Cambridge Consultants offers solutions across a diverse range of industries including medical technology, industrial and consumer products, digital health, energy and wireless communications.

About Capgemini Invent
As the digital innovation, design and transformation brand of the Capgemini Group, Capgemini Invent enables CxOs to envision and shape the future of their businesses. Located in nearly 40 studios and more than 60 offices around the world, it comprises a 10,000+ strong team of strategists, data scientists, product and experience designers, brand experts and technologists who develop new digital services, products, experiences and business models for sustainable growth.

Capgemini Invent is an integral part of Capgemini, a global leader in partnering with companies to transform and manage their business by harnessing the power of technology. The Group is guided everyday by its purpose of unleashing human energy through technology for an inclusive and sustainable future. It is a responsible and diverse organization of over 325,000 team members in more than 50 countries. With its strong 55-year heritage and deep industry expertise, Capgemini is trusted by its clients to address the entire breadth of their business needs, from strategy and design to operations, fueled by the fast evolving and innovative world of cloud, data, AI, connectivity, software, digital engineering and platforms. The Group reported in 2021 global revenues of €18 billion.

Get The Future You Want

Visit us at

Recent announcements

Deep tech

Are you curious about new technologies, and how they can lead to long-term sustainable value?

We think creatively at the intersection of business and technology, inventing solutions to redefine what you do.


You need a partner with intimate knowledge of your industry and proven experience of delivering value from deep tech breakthroughs.

Discover more about the work we do in your sector and how we can create real commercial advantage for you.


Take a look at the latest insights, ideas and perspectives from CC.

Explore a cross-section of up-to-date content on the deep tech trends shaping the future of business and society.


Are you looking for an opportunity for your abilities to be recognised, and make a real difference?

Whether you are just starting out or you’re an experienced professional, we would love to hear from you.